Xeljanz 5mg IND (Tofacitinib Citrate Tablet) 5mg

Xeljanz 5mg IND (Tofacitinib Citrate) is an oral tablet used for managing certain inflammatory conditions. It belongs to the JAK inhibitor class and is prescribed for adults with moderate to severe rheumatoid arthritis. Store at room temperature away from moisture.

Strength

5mg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

Pfizer Pharmaceutical LLC USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tofacitinib Citrate is primarily used to treat moderate to severe rheumatoid arthritis in adults who have not responded well to methotrexate. It may also be prescribed for psoriatic arthritis and ulcerative colitis, helping reduce inflammation and joint damage. This medication works by interfering with specific pathways in the immune system.

Side Effects

Users often report reduced joint pain and swelling after starting tofacitinib citrate. Some may experience improved mobility and daily functioning, though individual responses vary. Common effects include mild nausea or headache, which typically lessen over time.

Precautions & Warnings

Keep Xeljanz 5mg IND in its original packaging at room temperature. Avoid exposing it to excessive heat or moisture. Do not use if the packaging is damaged or the tablets appear discolored. Keep out of reach of children and pets.

Avoid Interactions

Tofacitinib citrate may interact with certain medications, including strong CYP3A4 inhibitors like ketoconazole or fluconazole. Combining it with immunosuppressants or biologics could increase infection risk. Always inform your healthcare provider about all medications you are taking.

References

Frequently Asked Questions

Xeljanz 5mg IND (Tofacitinib Citrate) is used to treat moderate to severe rheumatoid arthritis in adults who have not responded well to other medications.

Store Xeljanz 5mg IND at room temperature in a dry place, away from direct sunlight and moisture.

Consult your healthcare provider before combining Xeljanz with other drugs, as it may interact with certain medications like CYP3A4 inhibitors.

Common side effects may include mild nausea, headache, or diarrhea, which often improve with continued use.

No, Xeljanz 5mg IND is a targeted synthetic DMARD (disease-modifying antirheumatic drug), not a biologic.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.